1. Which term refers to the set of operations that establish the relationship between values indicated by an instrument and known reference standards?
2. In which situations may the Registration Board provisionally register a drug for a period of two years?
3. What is the condition under which printing of labeling for therapeutic goods is allowed under Schedule-II?
4. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
5. Which of the following offenses punishable under Schedule-III is non-cognizable?
6. What is the purpose of an "airlock" in pharmaceutical manufacturing?
7. What are the types of licences to manufacture drugs under Drugs Licensing, Registering & Advertising rules 1976?
8. What are "Medical Devices" under Schedule-I?
9. What does an Inspector require from a person during a search or seizure under Schedule-V?
10. What is the purpose of Form 10 in the export of drugs?
11. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
12. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
13. What is the primary function of the Federal Drug Laboratory as stated in the rules?
14. What are "Medicated Cosmetics" under Schedule-I?
15. In what situations can a drug or substance be advertised to the medical, pharmaceutical, and allied professions without referring to the Federal Government?
16. Which type of ophthalmic preparations is allowed to have a preservative?
17. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
18. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
19. Under what conditions are drug advertisements to the general public generally permitted?
20. Which type of research involves intervention, treatment, or medication programs using human subjects?
21. What is the role of the Appellate Board under The Drug Regulatory Authority of Pakistan Act, 2012?
22. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
23. In case an exporter's license is suspended or canceled, what recourse does the licensee have?
24. What is the primary focus of basic research in the context of the Drugs (Research) Rules?
25. Under what condition can finished drugs be imported?
26. What is the meaning of "sponsor" in the context of the Drugs (Research) Rules?
27. What is the purpose of the license to manufacture drugs for experimental purposes?
28. Under what conditions can the aid from the research fund be withdrawn and a clinical trial terminated?
29. The Drugs Act, 1976 extends to which of the following areas?
30. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
31. What form should be used for applying for the grant or renewal of a licence to manufacture drugs?
32. When can deviations be made from the information submitted during the registration of a drug?
33. When does an Inspector need to divide a sample into three portoons instead of four?
34. If any difficulty arises in giving effect to any provision of the DRAP Act, who has the authority to remove the difficulty?
35. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
36. Which authority may authorize a Federal Inspector to disclose information acquired during official duties?
37. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
38. What is the fee for submitting an appeal to the Appellate Board, as mentioned in the rules?
39. What is the maximum allowable retailer's discount for drugs?
40. What is the purpose of 'the Drugs (Federal Inspectors, Federal Drug Laboratory and Federal Government Analysts) Rules, 1976'?
41. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
42. Who may physically inspect an imported consignment, draw samples, and order the importer not to sell or dispose of the drug for a specific period?
43. What stage of investigation on human beings involves determining safety, effectiveness, and common side effects of a drug?
44. Which of the following substances would NOT be considered a "Medicated Cosmetic"?
45. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
46. What is the purpose of the Committee on Drugs Evaluation?
47. What is the consequence of violating the conditions of a license to import drugs or the provisions of the Act?
48. What is the purpose of the criteria regarding medical representatives?
49. What is the purpose of the Drugs (Research) Rules, 1978?
50. What does the term "batch number (or lot number)" refer to?
51. Who serves as the ex-officio Chairman of the Appellate Board?
52. What is the penalty for a person who fails to provide information requested by the Authority?
53. Which power of the Inspector requires specific authorization by the Government?
54. Which of the following criteria should promotional claims about drugs adhere to?
55. Who has the authority to physically inspect consignments of exported drugs and draw samples for testing?
56. What is the maximum period for which an Inspector can forbid a person in charge of premises from removing or dispensing therapeutic goods?
57. When does an Inspector need to divide a sample into three portoons instead of four?
58. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
59. In case of an appeal against the decision of the Registration Board rejecting an application for registration of a drug, what statement is required to be submitted?
60. Who is responsible for carrying out the audit of the Authority's accounts?
61. Within what time frame should the Authority submit its annual report to the Federal Government?
62. What is the duration of a license to import drugs, unless suspended or canceled?
63. Which of the following offenses punishable under Schedule-III is non-cognizable?
64. What is the definition of "promotion" for the purposes of Schedule G of 1976 Rules?
65. What is the duration of a license to export drugs?
66. Which court shall try an offense punishable under the DRAP Act, 2012, and The Drugs Act, 1976?
67. What provision allows an exporter to recall issues already made from a batch of drugs that have been found to be in contravention of the Act or rules of 1976?
68. For drugs other than those falling under specific categories, whose approval is required for the specifications?
69. What action should the Authority take in response to objections raised by the Auditor-General?
70. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
71. Under Schedule-II, what is allowed in terms of distributing therapeutic goods as samples?
72. What are "Medicated Cosmetics" under Schedule-I?
73. What ethical criteria should be followed for medical drug promotion?
74. What is the maximum duration of a licence issued under Drugs Licensing, Registering & Advertising rules 1976?
75. The Authority may open its accounts with:
76. What condition must be met for an application for renewal of a licence to be entertained?
77. Which Division is responsible for the evaluation, assessment, and registration of pharmaceutical drugs for human beings and animals?
78. What is the penalty for a person who fails to provide information requested by the Authority?
79. What substances are NOT included in the definition of "Drug" under Schedule-I?
80. What are "Medical Devices" under Schedule-I?
81. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
82. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
83. Who shall not be liable for a contravention of Section 23 of the Drugs Act 1976?
84. In what type of premises should the manufacturing of drugs by way of basic or semi-basic manufacture take place?
85. What is the term of office for members of the Registration Board?
86. What does the term "Advertise" mean under Schedule-II?
87. What are the conditions that the Central Licensing Board must ensure are complied with before granting or renewing a licence to manufacture drugs by way of basic or semi-basic manufacture?
88. What is the primary purpose of the Committee of Experts on Drug Research?
89. What degree qualifications are required for the competent technical staff involved in the manufacture of drugs by way of basic or semi-basic manufacture?
90. What is the penalty for a person who obstructs an Inspector in the exercise of any power conferred upon him under the Act?
91. What authority is responsible for inspecting and regulaying the manufacturing of drugs under 1976 rules?
92. What action should the Authority take in response to objections raised by the Auditor-General?
93. When a Federal Inspector is not competent to take action under Schedule-IV, what should he do?
94. What labeling requirements apply to drugs manufactured for experimental purposes?
95. The Authority shall levy and collect fees for its functions at rates determined by:
96. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
97. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
98. Under what conditions is contract manufacture permissible?
99. How many members does the Policy Board consist of?
100. Which authority is responsible for issuing licences to manufacture drugs by way of repacking under section 18 of ordinance in a province?
